Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methamphetamine | 3 | 2011 | 104 | 0.880 |
Why?
|
| Receptors, sigma | 3 | 2011 | 6 | 0.740 |
Why?
|
| Dopamine | 7 | 2011 | 276 | 0.730 |
Why?
|
| Nicotine | 5 | 2008 | 208 | 0.730 |
Why?
|
| Piperazines | 2 | 2011 | 284 | 0.580 |
Why?
|
| Nicotinic Agonists | 2 | 2008 | 73 | 0.530 |
Why?
|
| Motor Activity | 6 | 2014 | 323 | 0.510 |
Why?
|
| Central Nervous System Stimulants | 4 | 2014 | 233 | 0.480 |
Why?
|
| Cocaine | 4 | 2010 | 78 | 0.400 |
Why?
|
| Neostriatum | 2 | 2011 | 23 | 0.360 |
Why?
|
| Ketamine | 2 | 2008 | 26 | 0.340 |
Why?
|
| Hyperkinesis | 2 | 2008 | 14 | 0.340 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2008 | 78 | 0.340 |
Why?
|
| Nootropic Agents | 1 | 2011 | 12 | 0.330 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2008 | 87 | 0.330 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2010 | 29 | 0.320 |
Why?
|
| Locomotion | 1 | 2010 | 144 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2014 | 1236 | 0.290 |
Why?
|
| Pyrazoles | 2 | 2007 | 152 | 0.290 |
Why?
|
| Piperidines | 2 | 2007 | 163 | 0.280 |
Why?
|
| Cannabinoid Receptor Antagonists | 1 | 2006 | 2 | 0.250 |
Why?
|
| Prefrontal Cortex | 1 | 2008 | 150 | 0.250 |
Why?
|
| Naphthalenes | 1 | 2006 | 40 | 0.240 |
Why?
|
| Morpholines | 1 | 2006 | 61 | 0.240 |
Why?
|
| Analgesics | 1 | 2006 | 127 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 1908 | 0.230 |
Why?
|
| Rats | 7 | 2011 | 4028 | 0.210 |
Why?
|
| Corpus Striatum | 3 | 2007 | 83 | 0.180 |
Why?
|
| Tritium | 3 | 2008 | 113 | 0.150 |
Why?
|
| Animals | 11 | 2014 | 27973 | 0.140 |
Why?
|
| In Vitro Techniques | 3 | 2008 | 944 | 0.130 |
Why?
|
| Lobeline | 2 | 2007 | 4 | 0.130 |
Why?
|
| Amphetamine | 2 | 2014 | 101 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2014 | 13 | 0.110 |
Why?
|
| Nucleus Accumbens | 1 | 2014 | 113 | 0.100 |
Why?
|
| Drug Interactions | 2 | 2011 | 237 | 0.090 |
Why?
|
| Male | 9 | 2014 | 44360 | 0.090 |
Why?
|
| Ethylenediamines | 1 | 2011 | 14 | 0.080 |
Why?
|
| Discrimination Learning | 1 | 2011 | 63 | 0.080 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2010 | 29 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 302 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 269 | 0.080 |
Why?
|
| Ligands | 1 | 2010 | 476 | 0.070 |
Why?
|
| Brain | 2 | 2011 | 2337 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2008 | 313 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2007 | 13 | 0.060 |
Why?
|
| Receptors, Opioid | 1 | 2007 | 23 | 0.060 |
Why?
|
| Receptors, Opioid, mu | 1 | 2007 | 49 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 46 | 0.060 |
Why?
|
| Drug Antagonism | 1 | 2006 | 9 | 0.060 |
Why?
|
| Benzoxazines | 1 | 2006 | 5 | 0.060 |
Why?
|
| Narcotics | 1 | 2007 | 72 | 0.060 |
Why?
|
| Psychomotor Agitation | 1 | 2006 | 30 | 0.060 |
Why?
|
| Morphine | 1 | 2007 | 127 | 0.060 |
Why?
|
| Dextroamphetamine | 1 | 2007 | 108 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2006 | 39 | 0.060 |
Why?
|
| Narcotic Antagonists | 1 | 2007 | 170 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2007 | 389 | 0.050 |
Why?
|
| Neurons | 1 | 2008 | 1568 | 0.040 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2007 | 42 | 0.030 |
Why?
|
| Mice | 1 | 2010 | 12230 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 75 | 0.030 |
Why?
|
| Purines | 1 | 2014 | 91 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2014 | 1129 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 603 | 0.020 |
Why?
|
| Nomifensine | 1 | 2007 | 1 | 0.020 |
Why?
|
| Mecamylamine | 1 | 2007 | 4 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2007 | 32 | 0.020 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2007 | 21 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2007 | 136 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2007 | 162 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2007 | 138 | 0.020 |
Why?
|
| Oocytes | 1 | 2007 | 211 | 0.020 |
Why?
|
| Naltrexone | 1 | 2007 | 139 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2006 | 132 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 827 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 3497 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 4265 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2007 | 515 | 0.010 |
Why?
|
| Humans | 1 | 2010 | 93138 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 5380 | 0.010 |
Why?
|